Print this page

Income Statement of the Merck Group 

XLS

EUR million

Note

2010

2009

*

The figures for 2009 have been adjusted for the disclosure of royalty, license and commission expenses.

Sales

[1]

8,928.9

7,377.7

Royalty, license and commission income

[2]

361.7

369.3

Total revenues

 

9,290.6

7,747.0

 

 

 

 

Cost of sales

[3]

–2,385.4

–2,029.3

Gross margin

 

6,905.2

5,717.7

 

 

 

 

Marketing and selling expenses*

[4]

–2,234.5

–1,859.3

Royalty, license and commission expenses*

[5]

–477.0

–413.0

Administration expenses

[6]

–478.2

–424.9

Other operating expenses and income

[7]

–390.4

–372.7

Research and development

[8]

–1,397.1

–1,344.6

Amortization of intangible assets

[9]

–818.6

–657.8

Investment result

[10]

4.1

3.5

Operating result

 

1,113.5

648.9

 

 

 

 

Exceptional items

[11]

–0.8

–28.0

Earnings before interest and tax (EBIT)

 

1,112.7

620.9

 

 

 

 

Financial result

[12]

–251.6

–134.5

Profit before tax

 

861.1

486.4

 

 

 

 

Income tax

[13]

–219.6

–109.7

Profit after tax

 

641.5

376.7

 

 

 

 

Non-controlling interest

[14]

–9.4

–10.4

Net profit after non-controlling interest

 

632.1

366.3

 

 

 

 

Earnings per share (in EUR)

[15]

 

 

basic

 

2.91

1.68

diluted

 

2.91

1.68

© Merck KGaA, Darmstadt, Germany, Last Update 2010/02/23